PubMed

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P; Casale Monferrato Study.

Diabetes Care. 2004 Nov;27(11):2689-94.PMID: 15505006 [PubMed - indexed for MEDLINE]Related articlesFree article

Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo-Perin P; Casale Monferrato Study.

Diabetologia. 2005 Mar;48(3):427-34. Epub 2005 Feb 5.PMID: 15696295 [PubMed - indexed for MEDLINE]Related articles

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT.

JAMA. 2002 Dec 4;288(21):2709-16.PMID: 12460094 [PubMed - indexed for MEDLINE]Related articlesFree article

All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.

Doshi KB, Kashyap SR, Brennan DM, Hoar BM, Cho L, Hoogwerf BJ.

Diabetes Obes Metab. 2009 Feb;11(2):102-8. Epub 2008 May 20.PMID: 18494803 [PubMed - indexed for MEDLINE]Related articles

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group.

Arch Intern Med. 2004 May 24;164(10):1066-76.PMID: 15159263 [PubMed - indexed for MEDLINE]Related articlesFree article

C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Fornengo P, Novelli G, Panero F, Perotto M, Segre O, Zucco C, Deambrogio P, Bargero G, Perin PC.

Diabetes. 2009 Apr;58(4):926-33. Epub 2008 Dec 15.PMID: 19074985 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study.

Florkowski CM, Scott RS, Coope PA, Moir CL.

Diabetes Res Clin Pract. 2001 Aug;53(2):113-20.PMID: 11403860 [PubMed - indexed for MEDLINE]Related articles

Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.

Wild SH, Byrne CD, Smith FB, Lee AJ, Fowkes FG.

Diabetes Care. 2006 Mar;29(3):637-42.PMID: 16505519 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic syndrome and diabetes, alone and in combination, as predictors of cardiovascular disease mortality among men.

Church TS, Thompson AM, Katzmarzyk PT, Sui X, Johannsen N, Earnest CP, Blair SN.

Diabetes Care. 2009 Jul;32(7):1289-94. Epub 2009 Apr 14.PMID: 19366967 [PubMed - indexed for MEDLINE]Related articlesFree article

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.

Linnemann B, Voigt W, Nobel W, Janka HU.

Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):127-34.PMID: 16636979 [PubMed - indexed for MEDLINE]Related articles

Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.

Ko GT, So WY, Chan NN, Chan WB, Tong PC, Li J, Yeung V, Chow CC, Ozaki R, Ma RC, Cockram CS, Chan JC.

Diabetes Obes Metab. 2006 Jan;8(1):94-104.PMID: 16367887 [PubMed - indexed for MEDLINE]Related articles

The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.

Scuteri A, Najjar SS, Morrell CH, Lakatta EG; Cardiovascular Health Study.

Diabetes Care. 2005 Apr;28(4):882-7.PMID: 15793190 [PubMed - indexed for MEDLINE]Related articlesFree article

Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.

Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study.

Diabetes Care. 2005 Jun;28(6):1463-71.PMID: 15920069 [PubMed - indexed for MEDLINE]Related articlesFree article

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.

Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP; San Antonio Heart Study.

Circulation. 2004 Sep 7;110(10):1251-7. Epub 2004 Aug 23.PMID: 15326061 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE; Strong Heart Study Investigators.

Diabetes Care. 2007 Jul;30(7):1851-6. Epub 2007 Apr 17.PMID: 17440172 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.

Bruce DG, Davis WA, Starkstein SE, Davis TM.

Diabetologia. 2005 Dec;48(12):2532-9. Epub 2005 Nov 15.PMID: 16292463 [PubMed - indexed for MEDLINE]Related articles

Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.

Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2007 Feb;30(2):292-9.PMID: 17259497 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.

Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH; Finnish Diabetic Nephropathy (FinnDiane) Study Group.

Diabetes Care. 2009 May;32(5):950-2. Epub 2009 Feb 5.PMID: 19196885 [PubMed - indexed for MEDLINE]Related articlesFree article

[Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes]

Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julián B, Portilla Córdoba DP.

Rev Esp Cardiol. 2004 Jun;57(6):507-13. Spanish. PMID: 15225497 [PubMed - indexed for MEDLINE]Related articlesFree article